United States · FDA National Drug Code directory

DESVENLAFAXINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72603-555_34888df6-f68d-c171-e063-6294a90a7604
Product NDC
72603-555
Form
TABLET, EXTENDED RELEASE
Composition / generic term
DESVENLAFAXINE
Labeler
NorthStar Rx LLC
Marketing category
ANDA
Marketing start / end (source format)
20250502
Source listing expiry
20261231

Source-listed ingredients

  • DESVENLAFAXINE SUCCINATE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, EXTENDED RELEASE in 1 PACKAGE (72603-555-01) · 72603-555-01

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →